Delphi consensus on the physical health of patients with schizophrenia: Evaluation of the recommendations of the Spanish societies of psychiatry and biological psychiatry by a panel of experts

Actas Espanolas de Psiquiatria

Volumn 40, Issue 3, 2012, Pages 114-128

  Bobes García, Julio ^a   Saiz Ruiz, Jerónimo ^b   Bernardo Arroyo, Miquel ^c   Caballero Martinez, Fernando ^d   Gilaberte Asín, Inmaculada ^e   Ciudad Herrera, Antonio ^e  

^a UNIVERSITY OF OVIEDO   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSIDAD FRANCISCO DE VITORIA   (Spain)

^e ELI LILLY AND COMPANY   (Spain)

Author keywords

Intervention guides; Morbidity; Mortality; Physical health; Psychiatry; Schizophrenia

Indexed keywords

ARTICLE; CONSENSUS; DELPHI STUDY; HEALTH STATUS; HUMAN; MEDICAL SOCIETY; PRACTICE GUIDELINE; PSYCHIATRY; SCHIZOPHRENIA; SPAIN;

BIOLOGICAL PSYCHIATRY; CONSENSUS; DELPHI TECHNIQUE; HEALTH STATUS; HUMANS; PRACTICE GUIDELINES AS TOPIC; PSYCHIATRY; SCHIZOPHRENIA; SOCIETIES, MEDICAL; SPAIN;

EID: 84873669197     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. De Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care/Versión en Español. World Psychiatry. 2011; 10:52-77.
2. Sáiz Ruiz J, Bobes Garcia J, Vallejo Ruiloba J, Giner Ubago J, García-Portilla González MP; Grupo de Trabajo sobre la Salud Física del Paciente con Esquizofrenia. Consensu sobre la salud fisica del paciente con esquizofrenia de las Sociedades Españolas de Psiquiatria y de Psiquiatria Biológica. Actas Esp Psiquiatr. 2008;36:251-64.
3. Dickey B, Normand SL, Weiss RD, Drake RE, Azeni H. Medical morbidity, mental illness and substance use disorders. Psychiatr Serv. 2002;53:861-7.
4. Maj M. Necesidad de fomentar y proteger la salud física en personas con enfermedad mental grave [editorial]. Rev Psiquiatr Salud Ment (Barc.). 2009;2:1-4.
5. Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry. 2000;177:212-7.
6. Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular diseases. Am Heart J. 2005;150:1115-21.
7. Nasrallah HA An overview of common medical comorbidities in patients with schizophrenia. J Clin Psychiatry. 2005;66(Suppl 6):3-4.
8. Druss BG, Rosenheck RA. Mental disorders and access to medical care in the United States. Am J Psychiatry. 1998;155:1775-7.
9. Filik R, Sipos A, Kehoe PG, Burns T, Cooper SJ, Stevens H, et al. The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatr Scand. 2006; 113:298-305.
10. Cradock-O'Leary J, Young AS, Yano EM, Wang M, Lee ML Use of general medical services by VA patients with psychiatric disorders. Psychiatr Serv. 2002;53:874-8.
11. De Hert M, Bobes J, Cetkovich-Bakmas M, Cohen D, Leucht S, Maj M, et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry. 2011;10:138-51.
12. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27:596-601.
13. De Nayer A, de Hert M, Scheen A, Van Gaal L, Peuskens J. Conference report: Belgian consensus on metabolic problems associated with atypical antipsychotics. Encephale. 2007;33:197-202.
14. Koro CE, Fedder DO, L'Italien GJ, Weiss S, Magder LS, Kreyenbuhl J, et al. An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients. Arch Gen Psychiatry. 2002;59:1021-6.
15. Saiz-Ruiz J, Saiz-González MD, Alegría AA, Mena E, Luque J, Bobes J. Impacto del Consenso Español sobre la Salud Fisica del Paciente con Esquizofrenia. Rev Psiquiatr Salud Ment (Bare). 2010;3:119-27.
16. Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry. 2004;161:1334-49.
17. Baca Baldomero E, Leal Cercós C, Varela C, Riesgo Y, Roca M. Diagnóstico y manejo de la esquizofrenia en Spain: el proyecto ACEE. Actas Esp Psiquiatr. 2006;34:224-30.
18. Bobes J, Alegria AA, Saiz-Gonzalez MD, Barber I, Luque Pérez J, Saiz-Ruiz J. Change in psychiatrists' attitudes towards the physical health care of patients with schizophrenia coinciding with the dissemination of the Consensus on Physical Health in Patients with Schizophrenia. European Psychiatry. 2011; 26:305-12.
19. Dalkey NC. The Delphi Method: an experimental study of group opinion. Santa Monica, CA: RAND Corp, 1969. Publication RM-5888-PR.
20. Dalkey N, Brown B, Cochran S. The Delphi Method, III: Use of self ratings to improve group estimates. Santa Monica, CA: Rand Corporation, 1969. Publication RM-6115-PR.
21. Royle P, Waugh N. Literature searching for clinical and cost-effectiveness studies used in health technology assessments reports carried out for the National Institute for Clinical Excellence appraisal system. Health Technol Assess. 2003;7: iii, ix-x, 1-51.
22. Oxford Centre for Evidence-Based Medicine. Levels of Evidence, http://www.cebm.net/?o=1025.
23. Goodman LA. Snowball sampling. Ann Math Statist. 1961;32:148-70.
24. Lizaro P. Necesidad, adecuación y utilización de servicios sanitarios. Cap. 2 en: Otero LA, ed. Gestión clinica: desarrollo e instrumentos. Madrid: Ediciones Diaz de Santos, 2006.
25. Brook RH, Chassin MR, Fink A, Solomon DH, Kosecoff J, Park RE. A method for the detailed assessment of the appropriateness of medical technologies. Int J Tech Assess Health Care. 1986;2:53-63.
26. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 1997;157:1531-6.
27. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163:2716-24.
28. Peiró S, Portella E. El grupo nominal en el entorno sanitario. En: Quaderns de Salut Publica i Administraeió de Serveis de Salut. Valencia: Institut Valencià d'Estudis en Salut Pública, 2003.
29. Kahn DA, Docherty JP, Carpenter D. Frances A. Consensus methods in practice guideline development: a review and description of a new method. Psychopharmaeol Bull. 1997;33:631-9.
30. Frances A, Kahn D, Carpenter D, Frances C, Docherty J. A new method of developing expert consensus practice guidelines. Am J Manag Care. 1998;4:1023-9.
31. Holey EA, Feeley JL, Dixon J, Whittaker VJ. An exploration of the use of simple statistics to measure consensus and stability in Delphi studies. BMC Med Res Methodol. 2007;7:52.
32. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ. 1996;312:71-2.
33. Figueras Aloy J, Lopez Sastre J, Medrano Lopez C, Bermúdez- Cañete Fernández R, Fernández Pineda L, Bonillo Perales A, et al. Consenso multidisciplinar español sobre la profilaxis de la infección respiratoria pediátrics por virus respiratorio sincitial. An Pediatr (Barc). 2008;69:63-71.
34. Almansa C, Rey E, Bolaños E, Palma M, Álvarez Sánchez A, Díaz-Rubio M. Opinión de los médicos españoles sobre el síndrome de intestino irritable. Resultados de un estudio utilizando el método Delphi. Rev Esp Enferm Dig. 2007;99:210-7.
35. Dago Martinez A, Arcos González P, Álvarez de Toledo Saavedra F, Baena Parejo MI, Martínez Olmos J, Gorostiza Ormaetxe I. Indicadores de riesgo de morbilidad prevenible causada por medicamentos. Gac Sanit. 2007;21:29-36.
36. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540-5.
37. Izquierdo-Vicario Y, Ramos-Platón MJ, Conesa-Peraleja D, Lozano-Parra AB, Espinar-Sierra J. Epworth Sleepiness Scale in a sample of the Spanish population [letter]. Sleep. 1997;20:676-7.
38. Chiea-Urzola HL, Escobar-Córdoba F, Eslava-Schmalbach J. Validación de la escala de somnolencia de Epworth. Rev Salud Pública (Bogotá). 2007;9:558-67.